RecruitingNot ApplicableNCT04496895
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
Sponsor
TCI Co., Ltd.
Enrollment
124 participants
Start Date
Nov 12, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
To assess whether orange peel fermentation has the effect of reducing body fat in adults
Eligibility
Min Age: 20 YearsMax Age: 65 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Placebo and orange peel fermentation for people with fatty liver disease and overweight. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 65 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTPlacebo
consume 1 sachet per day for 2 months
DIETARY_SUPPLEMENTorange peel fermentation
consume 1 sachet per day for 2 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04496895
Related Trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
NCT0758960840 locations
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
NCT07321886162 locations
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT07369011129 locations
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600159 locations
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190173 locations